NKX2-8 and urinary bladder carcinoma: Our previous studies have demonstrated that downregulation of NKX2-8 significantly contributed to malignant progression and development of bladder cancer (10) and esophageal squamous carcinoma (11), and deletion of NKX2-8 conferred chemoresistance on epithelial ovarian cancer (13).